Information card for entry 7241518

Structure parameters

• Common name: clofaziminium diclofenac
• Chemical name: N-[(2E)-10-(4-chlorophenyl)-3-[(4-chlorophenyl)amino]-2,10- dihydrophenazin-2-ylidene]propan-2-aminium 2-{2- [(2,6-dichlorophenyl)amino]phenyl}acetate
• Formula: C41 H33 Cl4 N5 O2
• Calculated formula: C41 H33 Cl4 N5 O2
• SMILES: Clc1c(Nc2c(CC(=O)[O-])cccc2)c(Cl)ccc1.Clc1ccc([n+]2c3c(nc4ccccc24)cc(Nc2ccc(Cl)cc2)c(NC(C)C)c3)cc1
• Title of publication: Taking advantage of solvate formation to modulate drug–drug ratio in clofaziminium diclofenac salts
• Authors of publication: Bodart, Laurie; Prinzo, Maria; Derlet, Amélie; Tumanov, Nikolay; Wouters, Johan
• Journal of publication: CrystEngComm
• Year of publication: 2021
• Journal volume: 23
• Journal issue: 1
• Pages of publication: 185 - 201
• a: 12.4461 ± 0.0006 Å
• b: 13.2751 ± 0.0005 Å
• c: 13.3667 ± 0.0006 Å
• α: 84.423 ± 0.003°
• β: 67.963 ± 0.004°
• γ: 66.662 ± 0.004°
• Cell volume: 1876.21 ± 0.16 ų
• Cell temperature: 295 ± 2 K
• Ambient diffraction temperature: 295 ± 2 K
• Number of distinct elements: 5
• Space group number: 2
• Hermann-Mauguin space group symbol: P -1
• Hall space group symbol: -P 1
• Residual factor for all reflections: 0.0622
• Residual factor for significantly intense reflections: 0.048
• Weighted residual factors for significantly intense reflections: 0.1247
• Weighted residual factors for all reflections included in the refinement: 0.1409
• Goodness-of-fit parameter for all reflections included in the refinement: 1.028
• Diffraction radiation wavelength: 1.54184 Å
• Diffraction radiation type: CuKα
• Has coordinates: Yes
• Has disorder: No
• Has Fobs: No